Search Results for: Regeneron
Trials & Approvals Drug ApprovalClinical Trial
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
ASGCT 2024 ASGCT Previews
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
R&D Cholesterol
Pioneering Vaccine Offers Hope for Affordable Cholesterol Management
2023-12-20
Funding HHSCOVID-19
U.S. Government Awards $1.4 Billion to Advance COVID Therapies and Vaccines
2023-08-29
Feature biopharmaTherapeutics
GeneOnline’s Weekly News Highlights: Aug 21-25
2023-08-28
R&D TreatmentRegeneron Pharmaceuticals
Introducing Veopoz™: A Breakthrough Treatment for CHAPLE Disease
2023-08-28
Feature highlightsbiopharma
GeneOnline’s Weekly News Highlights: Aug 14-18
2023-08-21
Trials & Approvals FDA Approval
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Trials & Approvals Hypercholesterolemia
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Partnerships Regeneron
Regeneron Pays CytomX $2 Billion Biobucks to Develop Bispecific Cancer Therapies Together
2022-11-17
Policy Lawsuit
Supreme Court Rejects Juno, Welcomes Amgen Back to Patent Discussions
2022-11-08
Trials & Approvals Roche
Roche Clocks Clinical Win as it Eyes Additional Vabysmo Indication
2022-10-27
Trials & Approvals EMA
Atara, Pierre Fabre’s EBV T-Cell Therapy Recommended For Approval In Europe
2022-10-17
Trials & Approvals Cervical Cancer
EMA Signals Positive Opinion for Regeneron’s Cervical Cancer Monotherapy
2022-10-14
Dupixent
Sanofi and Regeneron’s Dupixent Snags its Tenth Approval From the FDA
2022-09-29
1 2 3 … 7
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top